Delivery Order SPE2DB22D2214-SPE2DB25FS6AE
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $5,281.82 on July 29, 2025, for the supply of Rexulti 2 mg tablets in quantities of 30. This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Rexulti is an atypical antipsychotic medication used in the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,492.36 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed-price contract type. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of August 8, 2025, one day following the August 7, 2025 award date. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this...
- The Defense Logistics Agency awarded a delivery order valued at $7,613.10 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (quantity: 30 count) under a firm fixed price contract. This non-competitive delivery order was issued on August 1, 2025, with an ultimate completion date of August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Rexulti (brexpiprazole) is an atypical antipsychotic medication used to treat schizophrenia and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Rexulti 2 mg tablets in a quantity of 30 units, with a ceiling value of $9,482.33. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on August 1, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rexulti 1 mg tablets (30-count packages) under a firm fixed-price contract valued at $5,508.44, with an ultimate completion date of July 25, 2025. This non-set-aside competitive award represents a single delivery order for a pharmaceutical product commonly prescribed for psychiatric conditions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Rexulti 2 mg tablets (30-count packages) with a ceiling value of $15,853.82. This competitively awarded, firm fixed-price delivery order is non-set-aside and carries an ultimate completion date of July 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $30,339.39 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count units) under a firm fixed price arrangement. The award, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's larger contract vehicle. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Rexulti 1 mg tablets (30-count units) with a ceiling value of $18,866.61. This non-set-aside contract award reflects a firm fixed price delivery order with an ultimate completion date of August 8, 2025. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $74,612.17. This non-competitive delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency Troop Support Medical awarded a $21,920.66 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 2 mg tablets of Rexulti in quantities of 30 tablets. The delivery order was awarded under an indefinite-delivery/indefinite-quantity contract vehicle and calls for Rexulti to be delivered to a facility in Conshohocken, Pennsylvania by September 14, 2023. As a major provider of pharmaceuticals and medical supplies to the U.S. Department of Defense, this...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6AEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count packages) with a ceiling value of $18,361.12. This firm fixed-price, non-set-aside delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Rexulti is an antipsychotic medication used in the treatment of psychiatric conditions, representing part of the broader pharmaceutical supply needs of the Department of Defense and military healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has demonstrated consistent capability to meet federal requirements through open competition across its extensive portfolio of delivery orders with the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.4k | 8/1/25 |